JMP Securities Downgrades Iovance Biotherapeutics (LSE:0JDK)
ソース:
NASDAQ Stocks
/
10 5 2025 01:18:12 America/Los_Angeles
Fintel reports that on May 9, 2025, JMP Securities downgraded their outlook for Iovance Biotherapeutics (LSE:0JDK) from Market Outperform to Market Perform. https://www.nasdaq.com/articles/jmp-securities-downgrades-iovance-biotherapeutics-lse-0jdk
シェアする